Millennium Pharmaceuticals Inc. decided to let someone else drive, or at least pay for the gas, in the development of its cardiovascular product, MLN519. (BioWorld Today)

Millennium Pharmaceuticals Inc. decided to let someone else drive, or at least pay for the gas, in the development of its cardiovascular product, MLN519. (BioWorld Today)

Celgene Corp. is facing a delay in its new drug application for Thalomid after the FDA said it had to conduct a new trial in a different indication, but one that may be more lucrative over time. (BioWorld Today)

Celgene Corp. is facing a delay in its new drug application for Thalomid after the FDA said it had to conduct a new trial in a different indication, but one that may be more lucrative over time. (BioWorld Today)

Centocor Inc.’s Remicade is inflating - both in uses and sales - having received a third approval in a rheumatoid arthritis indication. (BioWorld Today)

Centocor Inc.’s Remicade is inflating - both in uses and sales - having received a third approval in a rheumatoid arthritis indication. (BioWorld Today)

ImClone Systems Inc., after being dragged to scandalous depths not often seen in the biotechnology sector, bobbed to the surface Wednesday following its meeting with the FDA concerning the cancer drug Erbitux. (BioWorld Today)